Medexiq Labs Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 18-07-2024
- Paid Up Capital ₹ 2.00 M
as on 18-07-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2021
About Medexiq Labs
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sravani Suryadevara, Narendra Suryadevara, and Ravisankar Cherukuru serve as directors at the Company.
- CIN/LLPIN
U24299TG2018PTC124428
- Company No.
124428
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medexiq Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravisankar Cherukuru  | Managing Director | 22-Apr-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sravani Suryadevara | Director | 14-May-2018 | Current |
| Narendra Suryadevara | Director | 14-May-2018 | Current |
Financial Performance of Medexiq Labs.
Medexiq Labs Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medexiq Labs?
In 2019, Medexiq Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Amara Research Private LimitedActive 6 years 6 monthsSravani Suryadevara and Narendra Suryadevara are mutual person
Amara Labs Private LimitedActive 8 years 20 daysSravani Suryadevara, Narendra Suryadevara and 1 more are mutual person
- Amara Life Sciences Private LimitedActive 5 years 9 months
Sravani Suryadevara, Narendra Suryadevara and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medexiq Labs?
Unlock and access historical data on people associated with Medexiq Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medexiq Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medexiq Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
